Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective

Ferdinando Petrazzuoli1, Susanna Vestberg2, Patrik Midlöv1

  • 1Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö, Sweden.

Abstract

Insights

Differentiating mild cognitive impairment (MCI) from subjective cognitive decline (SCD) is crucial. Standard cognitive tests like MMSE and AQT showed limited accuracy in distinguishing between MCI and SCD in primary care settings.

Area of Science:

  • Neurology
  • Cognitive Science
  • Geriatrics

Background:

  • Distinguishing mild cognitive impairment (MCI) from subjective cognitive decline (SCD) is critical due to MCI's higher progression rate to dementia.
  • Accurate differentiation is essential for timely intervention and eligibility for future disease-modifying therapies indicated at the MCI stage.

Purpose of the Study:

  • To evaluate the accuracy of the Mini-Mental State Examination (MMSE), clock-drawing test (CDT), and Attention/Executive Functioning Questionnaire (AQT) in differentiating MCI from SCD.
  • To assess the efficacy of single tests and combinations of these cognitive assessments in a primary care setting.

Main Methods:

  • A cohort of 466 non-demented patients with cognitive complaints, referred to memory clinics, were classified as MCI (n=258) or SCD (n=208).
  • The diagnostic accuracy of MMSE, CDT, and AQT was assessed individually and in combination using training and validation samples.

Main Results:

  • The MMSE demonstrated the highest accuracy as a single test (sensitivity 73%, specificity 60%).
  • The combination of MMSE < 27 or AQT > 91 seconds showed improved specificity (78%) but not significantly better overall accuracy (AUC 0.76) compared to MMSE alone (AUC 0.75).
  • CDT and AQT performed significantly worse than MMSE, with no significant improvements noted for any combination of two or three tests.

Conclusions:

  • Current cognitive screening tests, including MMSE, CDT, and AQT, lack sufficient accuracy to reliably differentiate MCI from SCD in individuals seeking medical attention for cognitive symptoms.
  • There is a significant need for the development and validation of more accurate screening tools for primary care to enhance the early identification of MCI.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
440
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
674
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
443
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
319
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K